Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient.

Dermatol Ther

Faculty of Medicine, Department of Dermatology, Venereology and Andrology, Tanta University, Tanta, Egypt.

Published: November 2020

Onychomycosis is a common chronic fungal infection of the nails caused by dermatophytes, yeasts, and non-dermatophyte filamentous fungi. A relatively high incidence of resistance and treatment failure of onychomycosis to traditional systemic antifungal agents such as terbinafine and itraconazole has been reported. Voriconazole is a novel broad spectrum systemic antifungal that has shown high efficacy against various types of dermatophytes including Trichophyton and Microsporum species in many in vitro and, recently, in two in vivo studies of resistant dermatophytosis. Herein, we report the successful treatment of a resistant case of finger nail onychomycosis by oral voriconazole in a liver transplant patient who failed to respond to traditional systemic antifungals.

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.14014DOI Listing

Publication Analysis

Top Keywords

successful treatment
8
treatment resistant
8
voriconazole liver
8
liver transplant
8
transplant patient
8
traditional systemic
8
systemic antifungal
8
onychomycosis
4
resistant onychomycosis
4
onychomycosis voriconazole
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!